Gofen & Glossberg’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $317K | Buy |
4,253
+53
| +1% | +$3.95K | 0.01% | 415 |
|
|
2022
Q3 | $347K | Hold |
4,200
| – | – | 0.01% | 385 |
|
|
2022
Q2 | $399K | Hold |
4,200
| – | – | 0.01% | 362 |
|
|
2022
Q1 | $494K | Sell |
4,200
-885
| -17% | -$104K | 0.01% | 350 |
|
|
2021
Q4 | $659K | Sell |
5,085
-346
| -6% | -$44.8K | 0.01% | 306 |
|
|
2021
Q3 | $615K | Sell |
5,431
-1,700
| -24% | -$193K | 0.01% | 305 |
|
|
2021
Q2 | $739K | Sell |
7,131
-1,029
| -13% | -$107K | 0.02% | 278 |
|
|
2021
Q1 | $683K | Sell |
8,160
-200
| -2% | -$16.7K | 0.02% | 285 |
|
|
2020
Q4 | $763K | Sell |
8,360
-586
| -7% | -$53.5K | 0.02% | 260 |
|
|
2020
Q3 | $714K | Hold |
8,946
| – | – | 0.02% | 249 |
|
|
2020
Q2 | $618K | Buy |
8,946
+1,650
| +23% | +$114K | 0.02% | 252 |
|
|
2020
Q1 | $459K | Hold |
7,296
| – | – | 0.02% | 277 |
|
|
2019
Q4 | $567K | Sell |
7,296
-231
| -3% | -$18K | 0.02% | 275 |
|
|
2019
Q3 | $552K | Buy |
7,527
+246
| +3% | +$18K | 0.02% | 274 |
|
|
2019
Q2 | $448K | Buy |
7,281
+264
| +4% | +$16.2K | 0.02% | 299 |
|
|
2019
Q1 | $448K | Sell |
7,017
-270
| -4% | -$17.2K | 0.02% | 294 |
|
|
2018
Q4 | $372K | Buy |
7,287
+1,272
| +21% | +$64.9K | 0.01% | 301 |
|
|
2018
Q3 | $349K | Hold |
6,015
| – | – | 0.01% | 342 |
|
|
2018
Q2 | $292K | Hold |
6,015
| – | – | 0.01% | 364 |
|
|
2018
Q1 | $280K | Sell |
6,015
-1,365
| -18% | -$63.5K | 0.01% | 377 |
|
|
2017
Q4 | $277K | Hold |
7,380
| – | – | 0.01% | 400 |
|
|
2017
Q3 | $269K | Hold |
7,380
| – | – | 0.01% | 402 |
|
|
2017
Q2 | $291K | Hold |
7,380
| – | – | 0.01% | 377 |
|
|
2017
Q1 | $231K | Buy |
+7,380
| New | +$231K | 0.01% | 410 |
|